InvestorsHub Logo

JTORENCE

02/13/21 8:42 PM

#346001 RE: chrismiss_everyday #345998

chrissmiss Really?? The SEC/DOJ would love to get their teeth into something like that.

Did Gilead create an alias to allow for a significant buy-in with IPIX

Lemoncat

02/13/21 10:31 PM

#346011 RE: chrismiss_everyday #345998

Why bother?

21M shares is ~5% of IPIX shares. That's a rounding error for Gilead.

If IPIX goes to $5 that's $105M. That's less than 4% of Remdesivir's 2020 earnings.

If IPIX goes to $50 that's ~$1B or about 1.2% of Gilead's $83B market cap.

No, I don't think Gilead has anything to do with Kips Bay. If the phase 2 COVID trial goes well they will buy it for one or two or three billion.

Big pharma doesn't buy shares in OTC penny stocks. If they want them, they just acquire them in much the same way I would buy a pair of shoes at Macy's.

Go IPIX!


sunspotter

02/14/21 2:26 AM

#346016 RE: chrismiss_everyday #345998

“Did Gilead create an alias to allow for a significant buy-in with IPIX (for Brilacidin) that could be used synergistically with remdesivir in the not-too-distant future?”

No. And there are roughly a million reasons (I exaggerate slightly but not much) why that is a ludicrous fantasy.